|
General Information
|
|
|
Product
|
MEDEA Peptide
|
|
Description
|
Antigenic Blocking Peptide Medea Antibody
|
|
Verified Applications
|
Immunodepletion, Immunocompetition
|
|
Peptide Description
|
Synthetic peptide
|
|
Accession #
|
GenBank: AAC62005.1
|
|
Physical Properties
|
|
|
Quantity
|
250 µg
|
|
Volume
|
100 µl
|
|
Form
|
Antigenic Blocking Peptide
|
|
Storage
|
-20⁰C for long term storage
|
|
Application Protocol
|
|
Competition/Depletion assay
|
Refer to competition assay protocol
|
|
Protein
|
|
Uniprot #
|
Q7KPL1
|
|
Overview
|
Sequence-specific DNA binding transcription factor activity
|
|
Molecular Function
|
Transforming growth factor beta receptor, common-partner cytoplasmic mediator activity
|
|
Subcellular Location
|
Cytoplasm;Nucleus
|
|
Structure
|
Belongs to the dwarfin/SMAD family.
|
|
Alternative Nomenclature
|
(Small) Mothers Against Decapentaplegic antibody
Deleted in Pancreatic Carcinoma 4 antibody
DPC 4 antibody
hSMAD4 antibody
JIP antibody
MAD mothers against decapentaplegic homolog 4 antibody
MADH 4 antibody
Med antibody
Medea antibody
MYHRS antibody
Smad 4 antibody
|
| |
|
MEDEA Antibody
MEDEA Antibody FITC
MEDEA Antibody BIOTIN
MEDEA Positive Control
